Breaking News

The end of science's 'big ego' era; a mother's mission to advance custom medicines

    

 

Daily Recap

The fall of Eric Lander and the end of science's 'big ego' era

By Matthew Herper

Claudio Cruz/AP

For years, Eric Lander's camera-grabbing persona and big achievements were enough to grant indulgence for just about any sin. No more.

Read More

A mother, shaped by tragedy, embarks on a mission to advance custom medicines

By Jared Whitlock

Rachel Woolf for STAT

Julia Vitarello's daughter benefited from a medicine tailored specifically to her genetic condition. She says other children can benefit, too.

Read More

STAT+: Thirty Madison and Nurx to merge, as digital pharmacy companies outgrow their origins

By Mario Aguilar

Alissa Ambrose/STAT

Thirty Madison and Nurx announced Wednesday they intend to merge, hinting at the increasing maturity in the digital pharmacy market.

Read More

Researchers use ultrasound to precisely and safely activate brain cells in mice

By Jonathan Wosen

Adobe

The paper "shows that it's a real possibility" ultrasound can be used to directly modulate the activity of specific neurons, one expert said.

Read More

STAT+: Cost of a Vertex drug could worsen the global disparities in cystic fibrosis treatment, study finds

By Ed Silverman

Bill Sikes/AP

An analysis finds just 12% of people estimated to be living with cystic fibrosis in nearly 100 countries can access a highly effective drug.

Read More

Opinion: Covid-19 challenge trial results are (finally) in: Here's what should happen next

By Josh Morrison

BEN STANSALL/AFP via Getty Images

Covid-19 challenge trial results could help guide research for testing intranasal vaccines, new antiviral therapies, and more.

Read More

STAT+: South Africa's antitrust regulator wants Roche penalized for 'excessive' cancer drug pricing

By Ed Silverman

Jeff J Mitchell/Getty Images

"The impact of excessive pricing falls heavily on women, particularly poor women, who cannot access essential treatment," the agency explained

Read More

Wednesday, February 9, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments